Moderna and IBM announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management.
Initial work is planned to focus on exploring the utility of IBM capabilities in the U.S. including:
a) Digital Health Pass, built on blockchain technology: This is a solution designed to help individuals maintain control of their personal health information and share it in a way that is secured, verifiable and trusted. Organizations can use the solution to verify health credentials for employees, customers and travelers based on criteria specified by the organization, such as test results, vaccination records and temperature checks.
b) Vaccine management solutions that provide end-to-end traceability to address potential supply chain disruptions: The solutions enable governments and healthcare providers to quickly and securely share data regarding individual vaccine batches as they travel through the complex COVID-19 supply chain, from manufacturing facilities to administration sites.
The aim of the collaboration is identifying ways technology can be used to help accelerate secure, information sharing between governments, healthcare providers, life science organizations and individuals. In so doing, Moderna and IBM seek to improve confidence in vaccine programs and increase rates of vaccination, thereby reducing community spread.
Central to the effort will be a pilot of open, standardized, technology-enabled vaccine distribution approaches aimed to improve supply chain visibility and foster near real-time tracking of vaccine administration.
“If ever there was a time to rally around open technology and collaboration, it’s now,” said Jason Kelley, Managing Partner, Global Strategic Alliances Leader for IBM. “As governments, pharmacy chains, healthcare providers and life sciences companies continue to scale and connect their tools, and as new players enter the supply chain, open technology can help drive more transparency and bolster trust, while helping to ensure accessibility and equity in the process.”
The work with Moderna aligns with IBM’s efforts to help address the COVID-19 pandemic by providing access to its technology portfolio. At the outset of the pandemic, IBM joined the White House Office of Science and Technology Policy and other technology companies as part of the COVID-19 High Performance Computing Consortium, a partnership to give supercomputing resources to researchers to help speed the discovery and development of COVID-19 vaccines. IBM also offered its IBM Clinical Development (ICD) solution to eligible trial sponsor organizations as part of its medical community support efforts to help address the pandemic. The company received interest from numerous hospitals, sponsors, contract research organizations and academic institutions.
COVID-19.- IBM and Moderna collaborate to design a digital health pass built on blockchain
- Eva González
- 04/03/2021
- No Comments
Latest news
NATO members agree on a just one step process for Ukraine to join the North Atlantic Treaty Organisation
The invitation to join NATO and this shorter path for membership will not be issued and applied respectively with while the war keeps ongoing in Ukraine.
Chef José Andrés, to include first ever cultivated chicken dish in the menu of China Chilcano restaurant
Reservations to experience “Anticuchos de Pollo” dish made of cultivated chicken by José Andrés at China Chilcano restaurant will open from 25th July on.
Kyosk Digital Services improves fresh food produce distribution in Africa through KwikBasket purchase
With KwikBasket Kyosk is able to revolutionise the way fresh produce is sourced, distributed, and enjoyed in Africa catering to the needs of every stakeholder of the food value chain…
Africa's Renewable Energy: Looking Ahead
Though Africa’s climate and geography are ideally suited to take advantage of renewable energy, natural gas is the largest source of power in this continent at 45% in 2023, and…
Subway will add 4,000 new restaurants in Mainland China through sound master franchise agreement with leading local partners
Subway will grow its presence in Mainland China by more than seven times with this master franchise contract, the largest in Subway history.
Clean energy access gap's pace of reduction, far from achieving SDG7 by 2030, The Energy Progress Report warns
In 2021, 567 million people in sub-Saharan Africa did not have access to electricity, accounting for more than 80% of the global population in this situation.
Global energy crisis, boosting the highest ever jump of renewables worldwide: renewable power capacity expected to grow by a third this year with extended momentum in 2024
IEA tells about the largest increase in capacity and the highest rise ever in clean energy global investment with China accounting with 55% of additions of capacity
Ukraine's economy to grow between a 1 to 3% this year despite war uncertainty and paving the way steadily towards EU accession, IMF foresees
Ukraine will need $14Bn for critical and priority reconstruction and recovery investments just in 2023. Total rebuilding needs will amount to over $411Bn
Ukraine's Verkhovna rada approves tax exemptions to stimulate the manufacture and repair of drones inside the country
This is not the only measure aimed at stimulating national production and investment in Ukraine during the war and eyeing the after war rebuild period.
Japanese MUFG Bank announces investment in Indian fintech company DMI Finance
DMI Finance covers 95% of India's pincodes, has an accessible customer base of 25 mill and provides embeded fintech services for Samsung, Google and Airtel, as well as financial services…
New energy inflationary pressures in the horizon?.- OPEC approves additional 1.66 million b/d production cut effective from next May to the end of 2023
After the production cut announcement Brent price per barrel experienced a price hike of 5.31% to $84.13, the highest in almost a year.
US Federal Reserve increases interest rates a 0.25% despite SVB and SB fall outs
Pushing iflation down to the 2%, more important than already controlled fall outs of SVB and SB, but further increases will be carefully considered by USFR